Kevin Church - Feb 18, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Executive VP, Research
Signature
Glenna Mileson, Attorney-in-fact for Kevin Church
Stock symbol
ATHA
Transactions as of
Feb 18, 2022
Transactions value $
$3,751
Form type
4
Date filed
2/18/2022, 06:38 PM
Previous filing
Jan 20, 2022
Next filing
Jun 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Options Exercise $3.75K +3.15K +7.1% $1.19 47.6K Feb 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Options Exercise $0 -3.15K -100% $0.00* 0 Feb 18, 2022 Common Stock 3.15K $1.19 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option fully vested on September 1, 2017.